Bausch Health Companies Inc (BHC)

9.54
+0.03(+0.32%)
  • Volume:
    1,067,641
  • Bid/Ask:
    9.53/9.57
  • Day's Range:
    9.33 - 9.94

BHC Overview

Prev. Close
9.51
Day's Range
9.33-9.94
Revenue
10.76B
Open
9.61
52 wk Range
5.1-36.26
EPS
0.119
Volume
1,067,641
Market Cap
3.44B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,622,781
P/E Ratio
57.81
Beta
1.35
1-Year Change
-72.99%
Shares Outstanding
360,989,744
Next Earnings Date
Feb 22, 2023
What is your sentiment on Bausch Health?
or
Market is currently closed. Voting is open during market hours.

Bausch Health Companies Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Bausch Health Companies Inc Analysis

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
19600
  • Type:Equity
  • Market:Canada
  • ISIN:CA0717341071
  • CUSIP:071734107

Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.

Read More

Analyst Price Target

Average13.67 (+98.40% Upside)
High40
Low5
Price6.89
No. of Analysts9
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellSell
Technical IndicatorsStrong SellStrong SellStrong SellNeutralStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell
  • heading to 0???
    0
    • Bausch Health: How To Price The Calamities
      0
      • sell off and invest in safe heaven ETF G2X Xetra Germany in the best Gold Miners ETF .
        0
        • If the company doesn't file for bankruptcy (which I very much doubt and doesn't conclude from anywhere) this manic exaggeration a rare opportunity..
          1
          • Whats's happen?
            0
            • Patent lost . Stock halted
              0
            • could you share where did you get this info?
              0
          • wow
            0
            • Papa killed this stock. He made the biggest snafu in his life. It may take another 10 years to recover.
              0
              • can't believe this has fallen so low. this a buy, I can't imagine it won't rocket up unless bears still have plenty room to short.
                4
                • huge unlocking news today...hope for 10-20% boost
                  0
                  • March 16, 2021 7:03am HC Wainwright & Co. Maintains Buy on Bausch Health Companies, Raises Price Target to $55
                    0